Cytodyn Inc (CYDY)

[jimmy667]

I agree with this post. The original post made assumptions based on a misunderstanding of security laws.
Secondly there is no science backing the assumption that as infectivity goes up that potential for fatalities from the virus goes down. Further there is no science backing the assumption that infectivity is rising. A more reasonable assumption is that SOC is improving.
Most importantly share price reactions can not be accurately forecasted. Price has often gone down after PRs but is not predictable in magnitude. Yes selling the news is a thing and fear mongering is a thing as well.
FDA reactions are not predictable especially without the full data which the FDA may have but we do not.
Share price will have no bearing on or indication of future Regulatory actions. Frequently the market behaves opposite of what is expected.
The original post is just on persons emotional response and opinions. Trading on emotions whether fear, greed or FOMO is usually not advised. Smart money sells into strength and buys on weakness.
My opinion is CytoDyn is a long term winner and that Leronlimab is a very important emerging too for Covid. We will see if the FDA, based on the full data, believes a EUA is appropriate. Safety of Leronlimab weighs heavily in favor of a near term EUA.
I am a buyer on share price weakness and a holder on strength. The past week the CYDY price as the IBB XBI QQQ traded in lock step down. A reversal this coming week in Tech and Biotech might be a positive influence on CYDY.